Callahan Advisors, LLC Pfizer Inc Transaction History

Callahan Advisors, LLC

$986 Million
Q3 2024

A detailed history of Callahan Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Callahan Advisors, LLC holds 419,139 shares of PFE stock, worth $11.1 Million. This represents 1.23% of its overall portfolio holdings.

Number of Shares

419,139

Previous 385,377 8.76%

Holding current value

$11.1 Million

Previous $10.8 Million 12.49%

% of portfolio

1.23%

Previous 1.16%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	BUY	$27.7 - $31.39 $935,207 - $1.06 Million	33,762 Added 8.76%	419,139 $12.1 Million
Q2 2024 Jul 29, 2024	BUY	$25.26 - $29.6 $2.38 Million - $2.79 Million	94,140 Added 32.32%	385,377 $10.8 Million
Q1 2024 Apr 24, 2024	BUY	$25.89 - $29.73 $1.98 Million - $2.27 Million	76,429 Added 35.58%	291,237 $8.08 Million
Q4 2023 Jan 24, 2024	SELL	$26.13 - $33.94 $2.26 Million - $2.94 Million	-86,499 Reduced 28.71%	214,808 $6.18 Million
Q3 2023 Oct 23, 2023	SELL	$32.09 - $37.51 $639,906 - $747,986	-19,941 Reduced 6.21%	301,307 $9.99 Million
Q2 2023 Jul 31, 2023	BUY	$36.12 - $41.79 $96,151 - $111,244	2,662 Added 0.84%	321,248 $11.8 Million
Q1 2023 Apr 28, 2023	SELL	$39.39 - $51.28 $944,178 - $1.23 Million	-23,970 Reduced 7.0%	318,586 $13 Million
Q4 2022 Feb 03, 2023	SELL	$41.75 - $54.5 $659,608 - $861,045	-15,799 Reduced 4.41%	342,556 $17.6 Million
Q3 2022 Oct 27, 2022	SELL	$43.76 - $53.42 $393,402 - $480,245	-8,990 Reduced 2.45%	358,355 $15.7 Million
Q2 2022 Jul 29, 2022	SELL	$46.53 - $55.17 $722,797 - $857,010	-15,534 Reduced 4.06%	367,345 $19.3 Million
Q1 2022 Apr 27, 2022	SELL	$45.75 - $56.69 $591,227 - $732,604	-12,923 Reduced 3.27%	382,879 $19.8 Million
Q4 2021 Feb 08, 2022	BUY	$41.32 - $61.25 $1.53 Million - $2.27 Million	37,059 Added 10.33%	395,802 $23.4 Million
Q3 2021 Nov 03, 2021	BUY	$39.25 - $50.42 $577,210 - $741,476	14,706 Added 4.27%	358,743 $15.4 Million
Q2 2021 Aug 11, 2021	BUY	$35.91 - $40.68 $173,050 - $196,036	4,819 Added 1.42%	344,037 $13.5 Million
Q1 2021 Apr 21, 2021	BUY	$33.49 - $37.77 $216,345 - $243,994	6,460 Added 1.94%	339,218 $12.3 Million
Q4 2020 Jan 20, 2021	SELL	$33.47 - $42.56 $188,101 - $239,187	-5,620 Reduced 1.66%	332,758 $12.2 Million
Q3 2020 Oct 26, 2020	BUY	$31.75 - $37.25 $51,911 - $60,903	1,635 Added 0.49%	338,378 $12.4 Million
Q2 2020 Jul 17, 2020	BUY	$30.12 - $36.54 $375,536 - $455,580	12,468 Added 3.84%	336,743 $11 Million
Q1 2020 Apr 06, 2020	BUY	$27.03 - $38.62 $139,528 - $199,356	5,162 Added 1.62%	324,275 $10.6 Million
Q4 2019 Jan 21, 2020	BUY	$32.92 - $37.36 $185,570 - $210,598	5,637 Added 1.8%	319,113 $12.5 Million
Q3 2019 Oct 21, 2019	BUY	$32.49 - $42.13 $355,310 - $460,733	10,936 Added 3.61%	313,476 $11.3 Million
Q2 2019 Jul 17, 2019	SELL	$36.98 - $41.52 $19,081 - $21,424	-516 Reduced 0.17%	302,540 $13.1 Million
Q1 2019 Apr 22, 2019	BUY	$37.5 - $41.2 $241,912 - $265,781	6,451 Added 2.17%	303,056 $12.9 Million
Q4 2018 Jan 24, 2019	SELL	$38.47 - $43.86 $123,834 - $141,185	-3,219 Reduced 1.07%	296,605 $12.9 Million
Q3 2018 Oct 15, 2018	BUY	$34.47 - $41.81 $85,589 - $103,814	2,483 Added 0.84%	299,824 $13.2 Million
Q2 2018 Jul 19, 2018	BUY	$32.98 - $35.16 $135,910 - $144,894	4,121 Added 1.41%	297,341 $10.8 Million
Q1 2018 Apr 30, 2018	BUY	$31.91 - $37.02 $47,960 - $55,641	1,503 Added 0.52%	293,220 $10.4 Million
Q4 2017 Jan 31, 2018	BUY	$33.26 - $35.29 $64,557 - $68,497	1,941 Added 0.67%	291,717 $10.6 Million
Q3 2017 Oct 26, 2017	BUY	$31.0 - $34.15 $8.98 Million - $9.9 Million	289,776	289,776 $10.3 Million

Others Institutions Holding PFE

# of Institutions

3,259

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Callahan Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Callahan Advisors, LLC with notifications on news.

Account

Callahan Advisors, LLC Pfizer Inc Transaction History